Literature DB >> 15623192

Epidemiology of peripheral arterial disease.

C Diehm1, S Kareem, H Lawall.   

Abstract

Peripheral arterial disease (PAD) is not an uncommon but a commonly neglected condition by many medical practitioners. It is a disease that threatens not only the limb but also life itself! Atherosclerosis is the commonest cause of PAD in the western nations. The cardinal symptom is intermittent claudication (IC) but majority of the patients are asymptomatic. Ankle-brachial pressure index (ABI) is an effective screening tool for PAD. A diminished ABI (< 0.9) is a definite sign of PAD. Its prevalence steadily increases with age. In Germany almost a fifth of the patients aged over 65 years suffer from it. With increasing life expectancy the prevalence of PAD is on the increase. PAD is a manifestation of diffuse and severe atherosclerosis. It is a strong marker of cardiovascular disease; a very strong association exists between PAD and other atherosclerotic disorders such as coronary artery disease (CAD) and cerebrovascular disease (CVD). PAD is an independent predictor of high mortality in patients with CAD. Smoking, diabetes mellitus and advancing age are the cardinal risk factors. A relatively small number of PAD patients lose limbs by amputation. Most paitients with PAD die of either heart attacks or strokes and they die of the former conditions far earlier than controls. PAD still remains an esoteric disease and there is a significant lack of awareness of this condition by many physicians, and therefore under-diagnosed and underestimated. Measures to promote awareness of PAD among physicians and the society in general are needed. Since most patients are asymptomatic and carry potentially significant morbidity and mortality risks, screening for PAD should be made a routine practice at primary care level.

Entities:  

Mesh:

Year:  2004        PMID: 15623192     DOI: 10.1024/0301-1526.33.4.183

Source DB:  PubMed          Journal:  Vasa        ISSN: 0301-1526            Impact factor:   1.961


  21 in total

Review 1.  Clinical implications of skeletal muscle blood-oxygenation-level-dependent (BOLD) MRI.

Authors:  Sasan Partovi; Sasan Karimi; Bjoern Jacobi; Anja-Carina Schulte; Markus Aschwanden; Lisa Zipp; John K Lyo; Christof Karmonik; Matthias Müller-Eschner; Rolf W Huegli; Georg Bongartz; Deniz Bilecen
Journal:  MAGMA       Date:  2012-02-29       Impact factor: 2.310

Review 2.  Intermittent claudication.

Authors:  Kevin Cassar
Journal:  BMJ       Date:  2006-11-11

Review 3.  Whole-Body MRA.

Authors:  Harald Kramer; Harald H Quick; Bernd Tombach; Stefan O Schoenberg; Joerg Barkhausen
Journal:  Eur Radiol       Date:  2008-05-20       Impact factor: 5.315

4.  Pitavastatin calcium improves endothelial function and delays the progress of atherosclerosis in patients with hypercholesterolemia.

Authors:  Jing Zhao; Hui-min Yan; Ya Li; Jia Wang; Lu Han; Zhi-hao Wang; Meng-xiong Tang; Wei Zhang; Yun Zhang; Ming Zhong
Journal:  J Zhejiang Univ Sci B       Date:  2015-05       Impact factor: 3.066

5.  Detection of Peripheral Arterial Disease Within the Foot Using Vascular Optical Tomographic Imaging: A Clinical Pilot Study.

Authors:  M A Khalil; H K Kim; J W Hoi; I Kim; R Dayal; G Shrikhande; A H Hielscher
Journal:  Eur J Vasc Endovasc Surg       Date:  2015-01       Impact factor: 7.069

6.  The reliability of differentiating neurogenic claudication from vascular claudication based on symptomatic presentation.

Authors:  Mélissa Nadeau; M Patricia Rosas-Arellano; Kevin R Gurr; Stewart I Bailey; David C Taylor; Ruby Grewal; D Kirk Lawlor; Chris S Bailey
Journal:  Can J Surg       Date:  2013-12       Impact factor: 2.089

7.  The Viborg Vascular (VIVA) screening trial of 65-74 year old men in the central region of Denmark: study protocol.

Authors:  Nikolaj Grøndal; Rikke Søgaard; Eskild W Henneberg; Jes S Lindholt
Journal:  Trials       Date:  2010-05-27       Impact factor: 2.279

8.  Phosphocreatine kinetics in the calf muscle of patients with bilateral symptomatic peripheral arterial disease during exhaustive incremental exercise.

Authors:  Regina Esterhammer; Michael Schocke; Olaf Gorny; Lydia Posch; Hubert Messner; Werner Jaschke; Gustav Fraedrich; Andreas Greiner
Journal:  Mol Imaging Biol       Date:  2007-11-14       Impact factor: 3.488

Review 9.  [Screening in cardiovascular diseases].

Authors:  H Kramer; S Weckbach; G van Kaick; M F Reiser; S O Schoenberg
Journal:  Radiologe       Date:  2008-01       Impact factor: 0.635

Review 10.  Dacron vs. PTFE as bypass materials in peripheral vascular surgery--systematic review and meta-analysis.

Authors:  Stephanie Roll; Jacqueline Müller-Nordhorn; Thomas Keil; Hans Scholz; Daniela Eidt; Wolfgang Greiner; Stefan N Willich
Journal:  BMC Surg       Date:  2008-12-19       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.